Published in Oncogene on May 11, 2006
Disruption of p16 and activation of Kras in pancreas increase ductal adenocarcinoma formation and metastasis in vivo. Oncotarget (2011) 1.09
Role of phosphatidylinositol-3-kinase pathway in head and neck squamous cell carcinoma. J Oncol (2012) 1.01
Novel insight into mutational landscape of head and neck squamous cell carcinoma. PLoS One (2014) 0.97
Recent progress on liver kinase B1 (LKB1): expression, regulation, downstream signaling and cancer suppressive function. Int J Mol Sci (2014) 0.96
Tbx3 represses PTEN and is over-expressed in head and neck squamous cell carcinoma. BMC Cancer (2012) 0.90
Unravelling the connection between metabolism and tumorigenesis through studies of the liver kinase B1 tumour suppressor. J Carcinog (2013) 0.83
The Prognostic Value of Decreased LKB1 in Solid Tumors: A Meta-Analysis. PLoS One (2016) 0.82
Tongue carcinoma infrequently harbor common actionable genetic alterations. BMC Cancer (2014) 0.79
Frequent chromosomal aberrations and candidate genes in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol (2014) 0.75
Complexes between the LKB1 tumor suppressor, STRAD alpha/beta and MO25 alpha/beta are upstream kinases in the AMP-activated protein kinase cascade. J Biol (2003) 12.91
The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress. Proc Natl Acad Sci U S A (2004) 12.30
LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J (2004) 10.82
A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature (1998) 10.35
The LKB1 tumor suppressor negatively regulates mTOR signaling. Cancer Cell (2004) 7.77
Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet (1998) 7.36
Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. Cancer Res (2002) 7.09
Loss of the Lkb1 tumour suppressor provokes intestinal polyposis but resistance to transformation. Nature (2002) 6.10
Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology (2000) 5.40
Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases. Proc Natl Acad Sci U S A (2003) 4.87
Increased risk of cancer in the Peutz-Jeghers syndrome. N Engl J Med (1987) 4.55
Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat Genet (1997) 4.27
Growth suppression by Lkb1 is mediated by a G(1) cell cycle arrest. Proc Natl Acad Sci U S A (1999) 3.46
Vascular abnormalities and deregulation of VEGF in Lkb1-deficient mice. Science (2001) 2.99
Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol (1999) 2.59
The Peutz-Jegher gene product LKB1 is a mediator of p53-dependent cell death. Mol Cell (2001) 2.53
LKB1 (XEEK1) regulates Wnt signalling in vertebrate development. Nat Cell Biol (2003) 2.24
Role of Lkb1, the causative gene of Peutz-Jegher's syndrome, in embryogenesis and polyposis. Proc Natl Acad Sci U S A (2002) 1.83
LKB1 somatic mutations in sporadic tumors. Am J Pathol (1999) 1.79
Somatic mutations in LKB1 are rare in sporadic colorectal and testicular tumors. Cancer Res (1998) 1.75
Induction of cyclooxygenase-2 in a mouse model of Peutz-Jeghers polyposis. Proc Natl Acad Sci U S A (2002) 1.67
Hepatocellular carcinoma caused by loss of heterozygosity in Lkb1 gene knockout mice. Cancer Res (2002) 1.60
Somatic mutation of the Peutz-Jeghers syndrome gene, LKB1/STK11, in malignant melanoma. Oncogene (1999) 1.59
LIP1, a cytoplasmic protein functionally linked to the Peutz-Jeghers syndrome kinase LKB1. Hum Mol Genet (2001) 1.47
Mutations in the human LKB1/STK11 gene. Hum Mutat (2005) 1.45
Regulation of the Wnt signalling component PAR1A by the Peutz-Jeghers syndrome kinase LKB1. Oncogene (2003) 1.43
Novel mutations in the LKB1/STK11 gene in Dutch Peutz-Jeghers families. Hum Mutat (1999) 1.39
IGF-1 phosphorylates AMPK-alpha subunit in ATM-dependent and LKB1-independent manner. Biochem Biophys Res Commun (2004) 1.34
Somatic mutations in the Peutz-Jeghers (LKB1/STKII) gene in sporadic malignant melanomas. J Invest Dermatol (1999) 1.15
LKB1 protein expression in the evolution of glandular neoplasia of the lung. Clin Cancer Res (2003) 1.11
Functional analysis of LKB1/STK11 mutants and two aberrant isoforms found in Peutz-Jeghers Syndrome patients. Hum Mutat (2003) 1.06
SSCP analysis: a blind sensitivity trial. Hum Mutat (1997) 0.93
In situ analysis of LKB1/STK11 mRNA expression in human normal tissues and tumours. J Pathol (2000) 0.92
PTEN and LKB1 genes in laryngeal tumours. J Med Genet (1999) 0.81
Characterization of a murine Ahr null allele: involvement of the Ah receptor in hepatic growth and development. Proc Natl Acad Sci U S A (1996) 4.66
Progression model for pancreatic cancer. Clin Cancer Res (2000) 4.60
Tumor-suppressive pathways in pancreatic carcinoma. Cancer Res (1997) 4.54
Mesothelin is overexpressed in the vast majority of ductal adenocarcinomas of the pancreas: identification of a new pancreatic cancer marker by serial analysis of gene expression (SAGE). Clin Cancer Res (2001) 4.19
Unmetabolized folic acid in serum: acute studies in subjects consuming fortified food and supplements. Am J Clin Nutr (1997) 3.75
The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma. Clin Cancer Res (2001) 3.02
Immunohistochemical labeling for dpc4 mirrors genetic status in pancreatic adenocarcinomas : a new marker of DPC4 inactivation. Am J Pathol (2000) 2.63
Germline and somatic mutations of the STK11/LKB1 Peutz-Jeghers gene in pancreatic and biliary cancers. Am J Pathol (1999) 2.59
Discovery of new markers of cancer through serial analysis of gene expression: prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res (2001) 2.50
Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res (2000) 2.40
Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Cancer Res (1998) 2.23
Expression and functional significance of an additional ligand for CTLA-4. Proc Natl Acad Sci U S A (1993) 2.03
Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer. Clin Cancer Res (2001) 1.98
STK11/LKB1 Peutz-Jeghers gene inactivation in intraductal papillary-mucinous neoplasms of the pancreas. Am J Pathol (2001) 1.89
Unbalanced placental expression of imprinted genes in human intrauterine growth restriction. Placenta (2005) 1.73
PU. 1 is not essential for early myeloid gene expression but is required for terminal myeloid differentiation. Immunity (1995) 1.72
Analysis of PTEN/MMAC1 alterations in aerodigestive tract tumors. Cancer Res (1998) 1.71
Genetic, immunohistochemical, and clinical features of medullary carcinoma of the pancreas: A newly described and characterized entity. Am J Pathol (2000) 1.69
Molecular pathology of pancreatic cancer. Cancer J (2001) 1.56
Familial pancreatic cancer. Cancer J (2001) 1.51
PU.1 and Spi-B are required for normal B cell receptor-mediated signal transduction. Immunity (1999) 1.40
Familial pancreatic cancer. Ann Oncol (1999) 1.33
Identification and characterization of differentially methylated CpG islands in pancreatic carcinoma. Cancer Res (2001) 1.22
Aberrant methylation of the Human Hedgehog interacting protein (HHIP) gene in pancreatic neoplasms. Cancer Biol Ther (2005) 1.18
Tumor-suppressor genes in pancreatic cancer. J Hepatobiliary Pancreat Surg (1998) 1.17
Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms. Br J Cancer (2003) 1.16
Tongue lesions in the pediatric population. Otolaryngol Head Neck Surg (2001) 1.13
Pathology of incipient pancreatic cancer. Ann Oncol (1999) 1.10
Prevention and management of duodenal polyps in familial adenomatous polyposis. Gut (2005) 1.09
Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts. Cancer (2001) 1.05
Can we screen high-risk individuals to detect early pancreatic carcinoma? J Surg Oncol (2000) 1.00
Imprinting of PEG1/MEST isoform 2 in human placenta. Placenta (2005) 0.96
Expression of CD44 and its variants on gastric epithelial cells of patients with Helicobacter pylori colonisation. Gut (1996) 0.95
Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas. Br J Cancer (2011) 0.94
High-throughput drug screening of the DPC4 tumor-suppressor pathway in human pancreatic cancer cells. Ann Surg (2001) 0.91
[Retained foreign bodies from the surgical point of view]. Chirurg (2007) 0.90
Silencing of fat-1 transgene expression in sheep may result from hypermethylation of its driven cytomegalovirus (CMV) promoter. Theriogenology (2012) 0.89
Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and bile duct. Am J Clin Pathol (2001) 0.89
Molecular genetics and related developments in pancreatic cancer. Curr Opin Gastroenterol (1999) 0.89
Nuclear localization of Dpc4 (Madh4, Smad4) in colorectal carcinomas and relation to mismatch repair/transforming growth factor-beta receptor defects. Am J Pathol (2001) 0.86
Complete atresia of coronary ostia in pulmonary atresia and intact ventricular septum. Pediatr Cardiol (2003) 0.84
Genetic counseling and testing for germline p16 mutations in two pancreatic cancer-prone families. Gastroenterology (2000) 0.84
Seasonal variation of vitamin D in patients on hemodialysis. Clin Nephrol (2010) 0.83
Calcium and phosphate balance in dialysis patients. Kidney Int Suppl (1993) 0.82
Elevated levels of circulating soluble adhesion molecules in peripheral blood of patients with unstable angina. Am J Cardiol (1997) 0.82
Genetics of the FANCA gene in familial pancreatic cancer. J Med Genet (2004) 0.82
Elevated levels of circulating soluble adhesion molecules in patients with nonrheumatic aortic stenosis. Am J Cardiol (1997) 0.81
Does low-calcium dialysate accelerate secondary hyperparathyroidism in continuous ambulatory peritoneal dialysis patients? Perit Dial Int (1993) 0.79
BRCA2 and predisposition to pancreatic and other cancers. Expert Rev Mol Med (2001) 0.79
Novel homozygous deletions of chromosomal band 18q22 in pancreatic adenocarcinoma identified by STS marker scanning. Genes Chromosomes Cancer (1999) 0.78
Improved outcome of steroid withdrawal in mycophenolate mofetil-treated primary cadaveric renal transplant recipients. Transplant Proc (1999) 0.78
Carcinoma of the ampulla of Vater: a tumour with a poor prognosis? Eur J Gastroenterol Hepatol (1996) 0.78
Use and benefits of a Web site for pancreatic cancer. JAMA (1998) 0.77
Separate risk factors for the development of transplant glomerulopathy vs chronic tubulointerstitial rejection. Transplant Proc (1997) 0.77
Theophylline and sleep-disordered breathing in heart failure. N Engl J Med (1997) 0.75
Interferon first in chronic hepatitis C. BMJ (1993) 0.75
Cholesterol inhibition, cancer, and coronary heart disease. Lancet (1992) 0.75
Impact of pre-existing left ventricular dysfunction on kidney transplantation outcomes: implications for patient selection. Transplant Proc (2011) 0.75
Gujarat model of health management information system with reference to malaria. Indian J Malariol (1992) 0.75
Idiopathic constipation. Ir Med J (1996) 0.75
Non-accidental injury. Radiogr Today (1989) 0.75
Transplantation without maintenance corticosteroids in 1-haplotype and 2-haplotype HLA matched living-related renal transplant recipients treated with mycophenolate mofetil and cyclosporine. Transplant Proc (1999) 0.75
Recent developments in the medical management of peptic ulcer disease. Ir Med J (1994) 0.75
The gene encoding the transcription factor Spi-B maps to mouse chromosome 7. Mamm Genome (1997) 0.75
Benefit of angiotensin II receptor blockade in the treatment of posttransplant polycythemia in renal transplant recipients. Transplant Proc (1997) 0.75
Medical management of ulcerative colitis. Ir Med J (1993) 0.75
Role of tumor markers and mutations in cells and pancreatic juice in the diagnosis of pancreatic cancer. Ann Oncol (1999) 0.75
Nephrotic syndrome, renal vein thrombosis, and folate deficiency in a young man: is there a relationship to homocysteine metabolism? Nephrol Dial Transplant (1995) 0.75
Transplantation in peritoneal dialysis and hemodialysis. Kidney Int Suppl (1993) 0.75
Comparison of long-term actual renal allograft survival in mycophenolate mofetil and azathioprine-based triple drug immunosuppression protocols. Transplant Proc (2005) 0.75
Large lymph node metastasis gives hint to a glicentin positive small endocrine rectal carcinoma. Int J Colorectal Dis (2001) 0.75